$MNKD Headlines Stock market live blog: S&P 50
Post# of 144800
Posted On: 06/30/2014 12:57:17 PM
$MNKD Headlines
Stock market live blog: S&P 500 on track for biggest second-quarter gain since 2009 7 min ago - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 55 min ago - Sue Chang
MannKind shares up 23.1% in premarket trade 7:18 a.m. Today - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. Today - blogs.marketwatch.com
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - blogs.marketwatch.com
DuPont falls on outlook; Michaels debuts 4:07 p.m. June 27, 2014 - Saumya Vaishampayan
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:14 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:14 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Saumya Vaishampayan
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - blogs.marketwatch.com
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - blogs.marketwatch.com
Stock futures pare gains after ADP 8:58 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:13 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:13 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:53 p.m. April 1, 2014 - Wallace Witkowski
RBC Looks For Post-Approval Data On MannKind 11:37 a.m. Today - benzinga.com
Stocks on Track to Close Sixth Consecutive Quarter of Gains 10:53 a.m. Today - TheStreet.com
Vindication for MannKind on FDA Approval 9:54 a.m. Today - 247WallSt.com
A Classic Case of Kick the Can - Ahead of Wall Street 9:49 a.m. Today - Zacks.com
MannKind: Do Afrezza Label Woes Overshadow FDA Approval? 9:15 a.m. Today - Seeking Alpha
Another Giant Step Forward For Mankind And MannKind 8:47 a.m. Today - Seeking Alpha
MannKind Likely To Appreciate On A Post FDA Approval Short Squeeze 8:44 a.m. Today - Seeking Alpha
Afrezza Approval Opens The Door To Multi-Billion Dollar Markets For MannKind 8:32 a.m. Today - Seeking Alpha
MannKind: Is It Going To Soar Or Plummet? 8:27 a.m. Today - Seeking Alpha
MannKind: Strap Yourselves In And Prepare For Lift-Off... Or Not 8:22 a.m. Today - Seeking Alpha
U.S. Futures Dip Slightly; S&P to Close First Half 6% Higher 8:16 a.m. Today - TheStreet.com
MannKind Shares See #PreMarket Spike Following FDA Approval 7:25 a.m. Today - benzinga.com
MannKind set for opening gap up 7:07 a.m. Today - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:05 a.m. Today - benzinga.com
June 30 Premarket Briefing: 10 Things You Should Know 6:49 a.m. Today - TheStreet.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 4:00 a.m. Today - InvestorPlace.com
FDA OKs MannKind's Inhaled Insulin 5:28 p.m. June 27, 2014 - The Wall Street Journal Interactive Edition
FDA approves Afrezza 3:58 p.m. June 27, 2014 - Seeking Alpha
MannKind’s Afrezza Inhaled Insulin Drug Gets FDA Approval 3:47 p.m. June 27, 2014 - 247WallSt.com
Regarding Afrezza, FDA Statement: 2:33 p.m. June 27, 2014 - benzinga.com
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
Stock market live blog: S&P 500 on track for biggest second-quarter gain since 2009 7 min ago - blogs.marketwatch.com
MannKind, GoPro rise; Yahoo gains on upgrade 55 min ago - Sue Chang
MannKind shares up 23.1% in premarket trade 7:18 a.m. Today - Ciara Linnane
Six more bull months ahead, and GoPro keeps on going 6:28 a.m. Today - blogs.marketwatch.com
MannKind wins approval for its inhaled insulin — and its stock drops? 4:30 p.m. June 27, 2014 - blogs.marketwatch.com
DuPont falls on outlook; Michaels debuts 4:07 p.m. June 27, 2014 - Saumya Vaishampayan
3 overlooked stocks loved by top-ranked advisers 3:09 p.m. April 25, 2014 - Mark Hulbert
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
MannKind drops after FDA says its review on drug will last until July 1:46 p.m. April 7, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 9:20 a.m. April 7, 2014 - Sara Sjolin
MannKind drops 12% after FDA review extension 7:14 a.m. April 7, 2014 - Ben Eisen
MannKind drops 16% after FDA review extension 7:01 a.m. April 7, 2014 - Ben Eisen
U.S. stocks up; S&P 500 hits record 9:14 a.m. April 3, 2014 - Anora Mahmudova
MannKind soars on drug recommendation; Apollo slumps 4:13 p.m. April 2, 2014 - Saumya Vaishampayan
Myriad shares soar after Medicare reimbursements get a 37% boost 1:44 p.m. April 2, 2014 - blogs.marketwatch.com
MannKind shares nearly double after FDA panel OKs insulin treatment 10:40 a.m. April 2, 2014 - blogs.marketwatch.com
Stock futures pare gains after ADP 8:58 a.m. April 2, 2014 - Barbara Kollmeyer
MannKind: FDA committee recommends Afreeza OK 7:13 a.m. April 2, 2014 - MarketWatch.com
MannKind soars 97% after FDA panel nod for Afrezza 7:13 a.m. April 2, 2014 - Barbara Kollmeyer
Apollo shares slip after revenue falls short 6:53 p.m. April 1, 2014 - Wallace Witkowski
RBC Looks For Post-Approval Data On MannKind 11:37 a.m. Today - benzinga.com
Stocks on Track to Close Sixth Consecutive Quarter of Gains 10:53 a.m. Today - TheStreet.com
Vindication for MannKind on FDA Approval 9:54 a.m. Today - 247WallSt.com
A Classic Case of Kick the Can - Ahead of Wall Street 9:49 a.m. Today - Zacks.com
MannKind: Do Afrezza Label Woes Overshadow FDA Approval? 9:15 a.m. Today - Seeking Alpha
Another Giant Step Forward For Mankind And MannKind 8:47 a.m. Today - Seeking Alpha
MannKind Likely To Appreciate On A Post FDA Approval Short Squeeze 8:44 a.m. Today - Seeking Alpha
Afrezza Approval Opens The Door To Multi-Billion Dollar Markets For MannKind 8:32 a.m. Today - Seeking Alpha
MannKind: Is It Going To Soar Or Plummet? 8:27 a.m. Today - Seeking Alpha
MannKind: Strap Yourselves In And Prepare For Lift-Off... Or Not 8:22 a.m. Today - Seeking Alpha
U.S. Futures Dip Slightly; S&P to Close First Half 6% Higher 8:16 a.m. Today - TheStreet.com
MannKind Shares See #PreMarket Spike Following FDA Approval 7:25 a.m. Today - benzinga.com
MannKind set for opening gap up 7:07 a.m. Today - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:05 a.m. Today - benzinga.com
June 30 Premarket Briefing: 10 Things You Should Know 6:49 a.m. Today - TheStreet.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 4:00 a.m. Today - InvestorPlace.com
FDA OKs MannKind's Inhaled Insulin 5:28 p.m. June 27, 2014 - The Wall Street Journal Interactive Edition
FDA approves Afrezza 3:58 p.m. June 27, 2014 - Seeking Alpha
MannKind’s Afrezza Inhaled Insulin Drug Gets FDA Approval 3:47 p.m. June 27, 2014 - 247WallSt.com
Regarding Afrezza, FDA Statement: 2:33 p.m. June 27, 2014 - benzinga.com
MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes 5:07 p.m. June 27, 2014 - GlobeNewswire
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For Netflix, MannKind, Dish Network, Illumina, and Anheuser-Busch InBev Technology Released By InvestorsObserver 9:31 a.m. June 6, 2014 - PR Newswire - PRF
MannKind to Present at Upcoming Conferences 9:01 a.m. May 27, 2014 - GlobeNewswire
Reveal Insider Trading for Facebook, MannKind, QUALCOMM, American Realty Capital Properties, salesforce.com, and Symantec 8:55 a.m. May 22, 2014 - PR Newswire - PRF
Technical Data on Top Gainers -- Research on MannKind, Intermolecular, FireEye, and Yingli Green Energy Holding 9:10 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Critical Alerts For Citigroup, Linn Energy, MannKind, Canadian Solar, and Qualcomm Released By InvestorsObserver 9:31 a.m. May 15, 2014 - PR Newswire - PRF
MannKind Corporation Pending FDA Approval Inspires Analyst Report by BrokerBank Securities, Inc. 8:00 a.m. May 14, 2014 - PR Newswire - PRF
MannKind Corporation Reports 2014 First Quarter Financial Results 9:01 a.m. May 12, 2014 - GlobeNewswire
MannKind to Present at Bank of America Merrill Lynch 2014 Health Care Conference 5:01 p.m. May 7, 2014 - GlobeNewswire
MannKind Corporation to Hold 2014 First Quarter Financial Results Conference Call on May 12, 2014 9:01 a.m. May 5, 2014 - GlobeNewswire
Active Stocks Technical Review -- Research on AES Corp., Baidu, Hertz Global Holdings, and MannKind 1:01 p.m. April 30, 2014 - PR Newswire - PRF
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion 10:00 a.m. April 17, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:01 a.m. April 15, 2014 - ACCESSWIRE
Critical Alerts For Walt Disney, Walgreen, BioMarin Pharmaceuticals, Canadian Solar, and MannKind Released By InvestorsObserver 9:31 a.m. April 14, 2014 - PR Newswire - PRF
FDA Recommendations, Study Publications, Recognitions, Agreements, and Acquisitions - Analyst Notes on MannKind, Acceleron, Steris, Retrophin, and NxStage Medical 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Petr Announces Well Online and Estimates 26,000 Barrels of Oil per Day; MannKind's Afressa Drug Decision Extended by the FDA 1:05 a.m. April 8, 2014 - ACCESSWIRE
MannKind Updates Status of New Drug Application for AFREZZA(R) 4:00 a.m. April 7, 2014 - GlobeNewswire
Pre-Market Review on Top Gainers -- Research on MannKind, ZBB Energy, B2Gold, and DFC Global 9:08 a.m. April 3, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼